EKF Diagnostics Holdings plc (LON:EKF - Get Free Report) shot up 27.3% during trading on Thursday . The company traded as high as GBX 26.90 ($0.36) and last traded at GBX 25.20 ($0.34). 2,253,335 shares traded hands during mid-day trading, an increase of 353% from the average session volume of 497,132 shares. The stock had previously closed at GBX 19.80 ($0.26).
EKF Diagnostics Stock Up 4.4%
The company's 50 day moving average is GBX 21.44 and its 200 day moving average is GBX 23.85. The company has a market cap of £116.01 million, a PE ratio of 24.29 and a beta of 0.57. The company has a current ratio of 4.60, a quick ratio of 1.77 and a debt-to-equity ratio of 0.34.
EKF Diagnostics (LON:EKF - Get Free Report) last issued its earnings results on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) EPS for the quarter. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%. As a group, analysts predict that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current fiscal year.
Insider Buying and Selling
In other news, insider Gavin T. Jones bought 50,000 shares of the stock in a transaction on Tuesday, March 25th. The stock was acquired at an average cost of GBX 22 ($0.29) per share, for a total transaction of £11,000 ($14,692.13). 5.24% of the stock is owned by insiders.
About EKF Diagnostics
(
Get Free Report)
EKF is an AIM-listed global diagnostics business focussed on:
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
See Also
Before you consider EKF Diagnostics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EKF Diagnostics wasn't on the list.
While EKF Diagnostics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
